GMM Pfaudler Limited — Investor Meet, 14-11-2024: Analysts/Institutional Investor Meet/Con. Call Updates

Financial Performance: GMM Pfaudler Limited reported consolidated revenue of ₹805 crores and an EBITDA margin of 11.6% for Q2 FY25, reflecting a sequential growth of 3%. Standalone revenue was ₹208 crores with an EBITDA margin of 10.8%. The order intake for the quarter stood at ₹762 crores, with a backlog of ₹1,773 crores, marking a modest improvement from the previous period. Despite the revenue being lower than the previous year’s average, management holds a more optimistic outlook for Q3 and Q4 based on a healthier backlog and potential for increased shipments as production ramps up.

Future Outlook and Growth Drivers: The management emphasized a strong order intake of 18-20% half-yearly, anticipating robust performance in the upcoming quarters, particularly driven by the Heavy Engineering (HE) and mixing businesses. They foresee opportunities for double-digit growth in these segments, despite challenges in the glass-lined business due to muted investments in agrochemicals.

Order Book and Operational Updates: The order book shows a diversified portfolio, with significant contributions from non-glass lined technologies such as Edlon and Mavag. Operationally, inventories and unbilled revenues indicate an uptick in manufacturing activity, suggesting preparations for a more active delivery schedule in H2 FY25.

Analyst Q&A Insights: In discussions with analysts, management clarified its revenue projections, stating that while margins are under pressure due to competitive pricing, they expect improvements in the second half. Analysts expressed concern about the chemical sector's cyclical nature, but management remained confident in their diversification strategy, reducing reliance on any single industry.

Market or Regulatory Updates: Notable discussions around market sentiment indicate a shift towards investment in the pharmaceutical sector, especially in APIs, which could bolster future growth amidst sector-wide uncertainties.

Strategic Focus Areas: Management reiterated a focus on internal cost optimization and diversification of revenue streams beyond traditional sectors to mitigate cyclical risks. They have initiated projects aimed at EBITDA improvements and are exploring international growth, particularly in Poland.

Investor Insight: The company demonstrates a solid financial foundation with commendable order intake and strategic diversification, indicative of a 'buy' position. The proactive management approach to cost control and exploration of new markets presents potential for future growth, albeit with caution advised given the current market landscape.